日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases

家族性和散发性希腊卵巢癌病例中 BRCA1 突变的流行率

Alexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, Marianthi Tsitlaidou, Gerassimos E Voutsinas, Olga Triantafyllidou, Aristotelis Bamias, Meletios A Dimopoulos, Eleni Timotheadou, Dimitrios Pectasides, Christos Christodoulou, George Klouvas, Christos Papadimitriou, Thomas Makatsoris, Ge

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

XELIRI-贝伐单抗与 FOLFIRI-贝伐单抗作为转移性结直肠癌患者的一线治疗:一项希腊肿瘤合作组 III 期临床试验及其附带生物标志物分析

Dimitrios Pectasides, George Papaxoinis, Konstantine T Kalogeras, Anastasia G Eleftheraki, Ioannis Xanthakis, Thomas Makatsoris, Epaminondas Samantas, Ioannis Varthalitis, Pavlos Papakostas, Nikitas Nikitas, Christos N Papandreou, George Pentheroudakis, Eleni Timotheadou, Angelos Koutras, Joseph Sgo